Daiso Dental Product Recall [Australia]

Australia/Canberra: Daiso Industries (Australia) Pty Ltd recalls certain batch/lots of Dental Products including Toothpaste and Dental Floss due to suspected failure to comply with Australia’s Trade Practices (Consumer Product Information Standards) (Cosmetics) Regulations 1991. The recalled Toiletries do not have appropriate English language labelling identifying ingredients and any potential allergens, a serious health and safety hazard. ACCC: http://ht.ly/4nWn30dwFsC

Direct link: https://www.productsafety.gov.au/recall/daiso-industries-australia-pty-ltd-dental-products

Additional information:
The Australian Competition & Consumer Commission (“ACCC”) reports the following Dental Products are subject to this recall (in alphabetical order):

Bayer RestoraLAX Recall Expands [Canada]

Canada/Ottawa: Bayer Inc. expands its existing recall for certain batch/lots of RestoraLAX to include additional Laxative varieties due to the presence of clumps or lumps in the product and consequential choking hazard. HCSC: http://ht.ly/BT6F30dtmFS

Direct link: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2017/63908a-eng.php

Additional information:
Health Canada/Santé Canada (“HCSC”) reports the following Laxatives are subject to this recall:

Novopen Echo Insulin Device Recall [US]

US/Silver Spring: Novo Nordisk recalls certain batch/lots of Cartridge Holders for Novopen Echo Insulin Delivery Devices due to suspected risk of creaking and/or breakage and consequential Insulin delivery failure, Hyperglycemia and resultant life-threatening complications, all serious health hazards. FDA: http://ht.ly/Aquy30ds3rj

Direct link: https://www.fda.gov/Safety/Recalls/ucm565936.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following medical devices are subject to this recall:

Bayer RestoraLAX Laxative Recall [Canada]

Canada/Ottawa: Bayer Inc. recalls certain batch/lots of RestoraLAX Laxative due to presence of unexpected clumps or lumps in the product and consequential choking hazard. HCSC: http://ht.ly/fftt30dlGl3

Direct link: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2017/63798a-eng.php

Additional information:
Health Canada/Santé Canada (“HCSC”) reports the following Laxatives are subject to this recall:

Venture Catheter Recall [US]

US/Silver Spring: Vascular Solutions, Inc. recalls all batch/lots worldwide of Venture Catheters due to suspected extraneous material in the inner lumen of the distal Catheter tip and consequential component detachment or extrusion during use, embolism, serious injury and/or death hazards. FDA: http://ht.ly/Dkzn30d8YmD

Direct link: https://www.fda.gov/Safety/Recalls/ucm564419.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Catheters are subject to this recall (in alphanumeric order):

Bristol-Myers Squibb Eliquis Recall Update [US]

US/Silver Spring: Bristol-Myers Squibb updates its existing recall for one (1) batch/lots of Eliquis (apixaban) 5 mg Tablets due to suspected incorrect dosage packaging and consequential failure to protect against serious and life-changing cardiovascular events and/or Death, all serious health hazards. FDA: http://ht.ly/CpHA30cGw9G

Direct link: https://www.fda.gov/Safety/Recalls/ucm563547.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Drugs are subject to this recall:

Bristol-Myers Squibb Eliquis Recall [US]

US/Silver Spring: Bristol-Myers Squibb recalls one batch/lots of Eliquis (apixaban) 5 mg Tablets due to suspected incorrect dosage packaging and consequential failure to protect against serious and life-changing cardiovascular events and/or Death, all serious health hazards. FDA: http://ht.ly/7WzT30cB77V

Direct link: https://www.fda.gov/Safety/Recalls/ucm563002.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Drugs are subject to this recall: